Breakthrough Stem Cell Therapy in China Offers Hope for Type 1 Diabetes Patients

Published:16 June, 2025
Category: Diabetes, Stem Cell Therapy, Regenerative Medicine, China

🎯 A Milestone in Type 1 Diabetes Treatment Using Stem Cell Technology

In a groundbreaking achievement in regenerative medicine, researchers in China have successfully treated a 25-year-old woman with Type 1 diabetes (T1D) using personalized stem cell therapy. This cutting-edge therapy has enabled her body to naturally produce insulin, drastically reducing — and eventually eliminating — her reliance on daily insulin injections.

🔬 How the Stem Cell Treatment Worked

The innovative therapy, conducted at Tianjin First Central Hospital, involved converting the patient’s own fat cells (adipose-derived cells) into pluripotent stem cells (iPSCs) — cells that can develop into various cell types. Scientists used these to create insulin-producing islet cells, which were then transplanted into the patient’s abdominal tissue.

The stem cell-derived islets successfully engrafted, established blood supply, and began functioning like natural pancreatic islet cells. Remarkably, within 75 days, the patient’s blood glucose levels stabilized, and she became insulin-independent — a condition that has lasted for more than a year.

📈 Clinical Results: Improved HbA1c and Stable Blood Sugar

Doctors reported sustained improvement in the patient’s HbA1c levels, indicating long-term blood glucose control within the non-diabetic range. The woman continues to live insulin-free, a first for a T1D patient treated with stem-cell-derived islets in a clinical setting.

This first-in-human success case represents a significant step forward in stem cell therapy for diabetes, with two more patients currently undergoing similar treatment as part of an ongoing clinical trial in China.

🧬 Why This Matters for Global Type 1 Diabetes Treatment

Type 1 diabetes is an autoimmune disease where the body’s immune system destroys its insulin-producing beta cells. Traditional insulin therapy manages the condition but does not cure it. This new approach — using the patient’s own cells to regenerate islet function — could transform the future of diabetes care.

Experts believe this technique may eliminate the need for lifelong immunosuppressants, which are typically required in organ or cell transplantation.

🌍 Global Implications: Stem Cell Therapy as a Game Changer

With further validation, this method could pave the way for safe, personalized, and long-term treatment options for millions living with T1D worldwide. Several ongoing clinical trials in China and globally are now investigating similar cell-based diabetes therapies using stem cells.

📚 Reference

Wang S, et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell. 2024;187(22):6152–64.e18.

📞 Learn More or Collaborate

For scientific collaboration, press inquiries, or clinical consultation on stem cell therapy in China, please contact us or reach us on WhatsApp: +86 13585112357.